Affimed Therapeutics AG

Activities: Ingredients Pharmaceutical

Trending Articles

  1. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the...
  2. dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient
  3. Roche's cancer immunotherapy Tecentriq Hybreza bags FDA approval The drug first and only subcutaneous PD-(L)1 inhibitor available for patients with certain types of lung, skin, liver and soft tissue cancers
  4. Moderna's mRNA manufacturing facility bags Canadian Drug Establishment License The Canadian facility can now domestically manufacture a range of mRNA vaccines to treat respiratory viruses
  5. Genesis Pharma to distribute Santhera's Agamree for DMD The therapeutic recently received EC approval to treat patients over 4 years old with Duchenne muscular dystrophy

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Research & Development

Affimed Therapeutics appoints Chief Medical Officer

Jens-Peter Marschner joins the firm from Merck KGaA
Ingredients

Affimed reorganises management team

Adi Hoess becomes chief executive
Research & Development

Novel paths to treating rare diseases

Biotechnology is providing new pathways to treatments for many uncommon yet life-threatening diseases. Dr Sarah Houlton looks at some promising candidates
Ingredients

Affimed Therapeutics hires chief commercial officer

Adi Hoess joins the Heidelberg-based firm
Subscribe now